Creative Funding Options For China; Investors Battle Perception of Home Court Advantage
This article was originally published in PharmAsia News
Executive Summary
The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns